human lymphocytic t jurkat cells Search Results


human t cell leukemia cell line jurkat  (ATCC)
99
ATCC human t cell leukemia cell line jurkat
Human T Cell Leukemia Cell Line Jurkat, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human t cell leukemia cell line jurkat/product/ATCC
Average 99 stars, based on 1 article reviews
human t cell leukemia cell line jurkat - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier
gene exp tax1bp1 mm00518038 m1  (Thermo Fisher)
94
Thermo Fisher gene exp tax1bp1 mm00518038 m1
Gene Exp Tax1bp1 Mm00518038 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp tax1bp1 mm00518038 m1/product/Thermo Fisher
Average 94 stars, based on 1 article reviews
gene exp tax1bp1 mm00518038 m1 - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier
human t cell leukemia cell lines be 13  (DSMZ)
93
DSMZ human t cell leukemia cell lines be 13
Human T Cell Leukemia Cell Lines Be 13, supplied by DSMZ, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human t cell leukemia cell lines be 13/product/DSMZ
Average 93 stars, based on 1 article reviews
human t cell leukemia cell lines be 13 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier
jurkat  (DSMZ)
96
DSMZ jurkat
Proliferation and cytotoxicity of anti-CD30 CAR T-cells. (A) Schematic illustration of the anti-CD30 CAR (CD30-28z and CD30-28BBz) constructs. (B) Percentage of CAR+ T cells during the CAR T-cells (CD30-28z and CD30-28BBz) in vitro culture. (C) Total cell number at the time of transduction of anti-CD30 CAR T-cells (CD30-28z and CD30-28BBz). (D) The transgene copy number per one million CARS+ cells at the time of transduction of anti-CD30 CAR T-cells (CD30-28z and CD30-28BBz). (E) FACS was used to detect CD30 expression in negative cells (Raji, <t>Jurkat</t> and K562) and positive <t>cells</t> <t>(L428</t> and L540). Gray line: isotype control; Blue line: K562; Red line CD30 antibody and K562 overexpression CD30. (F) The calcein release assay was used for in vitro cytotoxicity testing at 3 different effectors: target ratios on CD30 negative cell lines as indicated. (G) The calcein release assay was used for in vitro cytotoxicity testing at 3 different effectors: target ratios on CD30 positive cell lines and K562-CD30 as indicated. (H–I) Anti-CD30 CAR T-cells were co-cultured with L428 cells. After 24 h, supernatants were collected for cytokine(IFNγ and IL-6) production analysis. All experiments were performed at least three independent times, and *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001. In the ( B,C,D,F,G ) black bar: T cells; green bar: CD30-28z; red bar: CD30-28BBz.
Jurkat, supplied by DSMZ, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/jurkat/product/DSMZ
Average 96 stars, based on 1 article reviews
jurkat - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier
jurkat cells  (ATCC)
94
ATCC jurkat cells
Proliferation and cytotoxicity of anti-CD30 CAR T-cells. (A) Schematic illustration of the anti-CD30 CAR (CD30-28z and CD30-28BBz) constructs. (B) Percentage of CAR+ T cells during the CAR T-cells (CD30-28z and CD30-28BBz) in vitro culture. (C) Total cell number at the time of transduction of anti-CD30 CAR T-cells (CD30-28z and CD30-28BBz). (D) The transgene copy number per one million CARS+ cells at the time of transduction of anti-CD30 CAR T-cells (CD30-28z and CD30-28BBz). (E) FACS was used to detect CD30 expression in negative cells (Raji, <t>Jurkat</t> and K562) and positive <t>cells</t> <t>(L428</t> and L540). Gray line: isotype control; Blue line: K562; Red line CD30 antibody and K562 overexpression CD30. (F) The calcein release assay was used for in vitro cytotoxicity testing at 3 different effectors: target ratios on CD30 negative cell lines as indicated. (G) The calcein release assay was used for in vitro cytotoxicity testing at 3 different effectors: target ratios on CD30 positive cell lines and K562-CD30 as indicated. (H–I) Anti-CD30 CAR T-cells were co-cultured with L428 cells. After 24 h, supernatants were collected for cytokine(IFNγ and IL-6) production analysis. All experiments were performed at least three independent times, and *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001. In the ( B,C,D,F,G ) black bar: T cells; green bar: CD30-28z; red bar: CD30-28BBz.
Jurkat Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/jurkat cells/product/ATCC
Average 94 stars, based on 1 article reviews
jurkat cells - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier
molt 4  (DSMZ)
94
DSMZ molt 4
Proliferation and cytotoxicity of anti-CD30 CAR T-cells. (A) Schematic illustration of the anti-CD30 CAR (CD30-28z and CD30-28BBz) constructs. (B) Percentage of CAR+ T cells during the CAR T-cells (CD30-28z and CD30-28BBz) in vitro culture. (C) Total cell number at the time of transduction of anti-CD30 CAR T-cells (CD30-28z and CD30-28BBz). (D) The transgene copy number per one million CARS+ cells at the time of transduction of anti-CD30 CAR T-cells (CD30-28z and CD30-28BBz). (E) FACS was used to detect CD30 expression in negative cells (Raji, <t>Jurkat</t> and K562) and positive <t>cells</t> <t>(L428</t> and L540). Gray line: isotype control; Blue line: K562; Red line CD30 antibody and K562 overexpression CD30. (F) The calcein release assay was used for in vitro cytotoxicity testing at 3 different effectors: target ratios on CD30 negative cell lines as indicated. (G) The calcein release assay was used for in vitro cytotoxicity testing at 3 different effectors: target ratios on CD30 positive cell lines and K562-CD30 as indicated. (H–I) Anti-CD30 CAR T-cells were co-cultured with L428 cells. After 24 h, supernatants were collected for cytokine(IFNγ and IL-6) production analysis. All experiments were performed at least three independent times, and *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001. In the ( B,C,D,F,G ) black bar: T cells; green bar: CD30-28z; red bar: CD30-28BBz.
Molt 4, supplied by DSMZ, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molt 4/product/DSMZ
Average 94 stars, based on 1 article reviews
molt 4 - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier
human t cell leukemia line ccrf cem cell  (ATCC)
96
ATCC human t cell leukemia line ccrf cem cell
Proliferation and cytotoxicity of anti-CD30 CAR T-cells. (A) Schematic illustration of the anti-CD30 CAR (CD30-28z and CD30-28BBz) constructs. (B) Percentage of CAR+ T cells during the CAR T-cells (CD30-28z and CD30-28BBz) in vitro culture. (C) Total cell number at the time of transduction of anti-CD30 CAR T-cells (CD30-28z and CD30-28BBz). (D) The transgene copy number per one million CARS+ cells at the time of transduction of anti-CD30 CAR T-cells (CD30-28z and CD30-28BBz). (E) FACS was used to detect CD30 expression in negative cells (Raji, <t>Jurkat</t> and K562) and positive <t>cells</t> <t>(L428</t> and L540). Gray line: isotype control; Blue line: K562; Red line CD30 antibody and K562 overexpression CD30. (F) The calcein release assay was used for in vitro cytotoxicity testing at 3 different effectors: target ratios on CD30 negative cell lines as indicated. (G) The calcein release assay was used for in vitro cytotoxicity testing at 3 different effectors: target ratios on CD30 positive cell lines and K562-CD30 as indicated. (H–I) Anti-CD30 CAR T-cells were co-cultured with L428 cells. After 24 h, supernatants were collected for cytokine(IFNγ and IL-6) production analysis. All experiments were performed at least three independent times, and *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001. In the ( B,C,D,F,G ) black bar: T cells; green bar: CD30-28z; red bar: CD30-28BBz.
Human T Cell Leukemia Line Ccrf Cem Cell, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human t cell leukemia line ccrf cem cell/product/ATCC
Average 96 stars, based on 1 article reviews
human t cell leukemia line ccrf cem cell - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier
human t cell leukemia cell line hpb  (DSMZ)
96
DSMZ human t cell leukemia cell line hpb
Proliferation and cytotoxicity of anti-CD30 CAR T-cells. (A) Schematic illustration of the anti-CD30 CAR (CD30-28z and CD30-28BBz) constructs. (B) Percentage of CAR+ T cells during the CAR T-cells (CD30-28z and CD30-28BBz) in vitro culture. (C) Total cell number at the time of transduction of anti-CD30 CAR T-cells (CD30-28z and CD30-28BBz). (D) The transgene copy number per one million CARS+ cells at the time of transduction of anti-CD30 CAR T-cells (CD30-28z and CD30-28BBz). (E) FACS was used to detect CD30 expression in negative cells (Raji, <t>Jurkat</t> and K562) and positive <t>cells</t> <t>(L428</t> and L540). Gray line: isotype control; Blue line: K562; Red line CD30 antibody and K562 overexpression CD30. (F) The calcein release assay was used for in vitro cytotoxicity testing at 3 different effectors: target ratios on CD30 negative cell lines as indicated. (G) The calcein release assay was used for in vitro cytotoxicity testing at 3 different effectors: target ratios on CD30 positive cell lines and K562-CD30 as indicated. (H–I) Anti-CD30 CAR T-cells were co-cultured with L428 cells. After 24 h, supernatants were collected for cytokine(IFNγ and IL-6) production analysis. All experiments were performed at least three independent times, and *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001. In the ( B,C,D,F,G ) black bar: T cells; green bar: CD30-28z; red bar: CD30-28BBz.
Human T Cell Leukemia Cell Line Hpb, supplied by DSMZ, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human t cell leukemia cell line hpb/product/DSMZ
Average 96 stars, based on 1 article reviews
human t cell leukemia cell line hpb - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier
human t cell leukemia line  (CEM Corporation)
90
CEM Corporation human t cell leukemia line
Proliferation and cytotoxicity of anti-CD30 CAR T-cells. (A) Schematic illustration of the anti-CD30 CAR (CD30-28z and CD30-28BBz) constructs. (B) Percentage of CAR+ T cells during the CAR T-cells (CD30-28z and CD30-28BBz) in vitro culture. (C) Total cell number at the time of transduction of anti-CD30 CAR T-cells (CD30-28z and CD30-28BBz). (D) The transgene copy number per one million CARS+ cells at the time of transduction of anti-CD30 CAR T-cells (CD30-28z and CD30-28BBz). (E) FACS was used to detect CD30 expression in negative cells (Raji, <t>Jurkat</t> and K562) and positive <t>cells</t> <t>(L428</t> and L540). Gray line: isotype control; Blue line: K562; Red line CD30 antibody and K562 overexpression CD30. (F) The calcein release assay was used for in vitro cytotoxicity testing at 3 different effectors: target ratios on CD30 negative cell lines as indicated. (G) The calcein release assay was used for in vitro cytotoxicity testing at 3 different effectors: target ratios on CD30 positive cell lines and K562-CD30 as indicated. (H–I) Anti-CD30 CAR T-cells were co-cultured with L428 cells. After 24 h, supernatants were collected for cytokine(IFNγ and IL-6) production analysis. All experiments were performed at least three independent times, and *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001. In the ( B,C,D,F,G ) black bar: T cells; green bar: CD30-28z; red bar: CD30-28BBz.
Human T Cell Leukemia Line, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human t cell leukemia line/product/CEM Corporation
Average 90 stars, based on 1 article reviews
human t cell leukemia line - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
human t-cell leukemia virus type 1  (Inserm Transfert)
90
Inserm Transfert human t-cell leukemia virus type 1
Proliferation and cytotoxicity of anti-CD30 CAR T-cells. (A) Schematic illustration of the anti-CD30 CAR (CD30-28z and CD30-28BBz) constructs. (B) Percentage of CAR+ T cells during the CAR T-cells (CD30-28z and CD30-28BBz) in vitro culture. (C) Total cell number at the time of transduction of anti-CD30 CAR T-cells (CD30-28z and CD30-28BBz). (D) The transgene copy number per one million CARS+ cells at the time of transduction of anti-CD30 CAR T-cells (CD30-28z and CD30-28BBz). (E) FACS was used to detect CD30 expression in negative cells (Raji, <t>Jurkat</t> and K562) and positive <t>cells</t> <t>(L428</t> and L540). Gray line: isotype control; Blue line: K562; Red line CD30 antibody and K562 overexpression CD30. (F) The calcein release assay was used for in vitro cytotoxicity testing at 3 different effectors: target ratios on CD30 negative cell lines as indicated. (G) The calcein release assay was used for in vitro cytotoxicity testing at 3 different effectors: target ratios on CD30 positive cell lines and K562-CD30 as indicated. (H–I) Anti-CD30 CAR T-cells were co-cultured with L428 cells. After 24 h, supernatants were collected for cytokine(IFNγ and IL-6) production analysis. All experiments were performed at least three independent times, and *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001. In the ( B,C,D,F,G ) black bar: T cells; green bar: CD30-28z; red bar: CD30-28BBz.
Human T Cell Leukemia Virus Type 1, supplied by Inserm Transfert, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human t-cell leukemia virus type 1/product/Inserm Transfert
Average 90 stars, based on 1 article reviews
human t-cell leukemia virus type 1 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
jcb 0830 leukemia t cell  (ATCC)
96
ATCC jcb 0830 leukemia t cell
Proliferation and cytotoxicity of anti-CD30 CAR T-cells. (A) Schematic illustration of the anti-CD30 CAR (CD30-28z and CD30-28BBz) constructs. (B) Percentage of CAR+ T cells during the CAR T-cells (CD30-28z and CD30-28BBz) in vitro culture. (C) Total cell number at the time of transduction of anti-CD30 CAR T-cells (CD30-28z and CD30-28BBz). (D) The transgene copy number per one million CARS+ cells at the time of transduction of anti-CD30 CAR T-cells (CD30-28z and CD30-28BBz). (E) FACS was used to detect CD30 expression in negative cells (Raji, <t>Jurkat</t> and K562) and positive <t>cells</t> <t>(L428</t> and L540). Gray line: isotype control; Blue line: K562; Red line CD30 antibody and K562 overexpression CD30. (F) The calcein release assay was used for in vitro cytotoxicity testing at 3 different effectors: target ratios on CD30 negative cell lines as indicated. (G) The calcein release assay was used for in vitro cytotoxicity testing at 3 different effectors: target ratios on CD30 positive cell lines and K562-CD30 as indicated. (H–I) Anti-CD30 CAR T-cells were co-cultured with L428 cells. After 24 h, supernatants were collected for cytokine(IFNγ and IL-6) production analysis. All experiments were performed at least three independent times, and *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001. In the ( B,C,D,F,G ) black bar: T cells; green bar: CD30-28z; red bar: CD30-28BBz.
Jcb 0830 Leukemia T Cell, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/jcb 0830 leukemia t cell/product/ATCC
Average 96 stars, based on 1 article reviews
jcb 0830 leukemia t cell - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier
molt 4  (ATCC)
99
ATCC molt 4
Proliferation and cytotoxicity of anti-CD30 CAR T-cells. (A) Schematic illustration of the anti-CD30 CAR (CD30-28z and CD30-28BBz) constructs. (B) Percentage of CAR+ T cells during the CAR T-cells (CD30-28z and CD30-28BBz) in vitro culture. (C) Total cell number at the time of transduction of anti-CD30 CAR T-cells (CD30-28z and CD30-28BBz). (D) The transgene copy number per one million CARS+ cells at the time of transduction of anti-CD30 CAR T-cells (CD30-28z and CD30-28BBz). (E) FACS was used to detect CD30 expression in negative cells (Raji, <t>Jurkat</t> and K562) and positive <t>cells</t> <t>(L428</t> and L540). Gray line: isotype control; Blue line: K562; Red line CD30 antibody and K562 overexpression CD30. (F) The calcein release assay was used for in vitro cytotoxicity testing at 3 different effectors: target ratios on CD30 negative cell lines as indicated. (G) The calcein release assay was used for in vitro cytotoxicity testing at 3 different effectors: target ratios on CD30 positive cell lines and K562-CD30 as indicated. (H–I) Anti-CD30 CAR T-cells were co-cultured with L428 cells. After 24 h, supernatants were collected for cytokine(IFNγ and IL-6) production analysis. All experiments were performed at least three independent times, and *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001. In the ( B,C,D,F,G ) black bar: T cells; green bar: CD30-28z; red bar: CD30-28BBz.
Molt 4, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molt 4/product/ATCC
Average 99 stars, based on 1 article reviews
molt 4 - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

Image Search Results


Proliferation and cytotoxicity of anti-CD30 CAR T-cells. (A) Schematic illustration of the anti-CD30 CAR (CD30-28z and CD30-28BBz) constructs. (B) Percentage of CAR+ T cells during the CAR T-cells (CD30-28z and CD30-28BBz) in vitro culture. (C) Total cell number at the time of transduction of anti-CD30 CAR T-cells (CD30-28z and CD30-28BBz). (D) The transgene copy number per one million CARS+ cells at the time of transduction of anti-CD30 CAR T-cells (CD30-28z and CD30-28BBz). (E) FACS was used to detect CD30 expression in negative cells (Raji, Jurkat and K562) and positive cells (L428 and L540). Gray line: isotype control; Blue line: K562; Red line CD30 antibody and K562 overexpression CD30. (F) The calcein release assay was used for in vitro cytotoxicity testing at 3 different effectors: target ratios on CD30 negative cell lines as indicated. (G) The calcein release assay was used for in vitro cytotoxicity testing at 3 different effectors: target ratios on CD30 positive cell lines and K562-CD30 as indicated. (H–I) Anti-CD30 CAR T-cells were co-cultured with L428 cells. After 24 h, supernatants were collected for cytokine(IFNγ and IL-6) production analysis. All experiments were performed at least three independent times, and *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001. In the ( B,C,D,F,G ) black bar: T cells; green bar: CD30-28z; red bar: CD30-28BBz.

Journal: Scientific Reports

Article Title: The third-generation anti-CD30 CAR T-cells specifically homing to the tumor and mediating powerful antitumor activity

doi: 10.1038/s41598-022-14523-0

Figure Lengend Snippet: Proliferation and cytotoxicity of anti-CD30 CAR T-cells. (A) Schematic illustration of the anti-CD30 CAR (CD30-28z and CD30-28BBz) constructs. (B) Percentage of CAR+ T cells during the CAR T-cells (CD30-28z and CD30-28BBz) in vitro culture. (C) Total cell number at the time of transduction of anti-CD30 CAR T-cells (CD30-28z and CD30-28BBz). (D) The transgene copy number per one million CARS+ cells at the time of transduction of anti-CD30 CAR T-cells (CD30-28z and CD30-28BBz). (E) FACS was used to detect CD30 expression in negative cells (Raji, Jurkat and K562) and positive cells (L428 and L540). Gray line: isotype control; Blue line: K562; Red line CD30 antibody and K562 overexpression CD30. (F) The calcein release assay was used for in vitro cytotoxicity testing at 3 different effectors: target ratios on CD30 negative cell lines as indicated. (G) The calcein release assay was used for in vitro cytotoxicity testing at 3 different effectors: target ratios on CD30 positive cell lines and K562-CD30 as indicated. (H–I) Anti-CD30 CAR T-cells were co-cultured with L428 cells. After 24 h, supernatants were collected for cytokine(IFNγ and IL-6) production analysis. All experiments were performed at least three independent times, and *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001. In the ( B,C,D,F,G ) black bar: T cells; green bar: CD30-28z; red bar: CD30-28BBz.

Article Snippet: L428 and L540(Human Hodgkin’s lymphoma cell line) were purchased from the DSMZ, Jurkat (Human T cell leukemia), K-562 (human chronic myeloid leukemia) and Raji (human lymphoblastic Burkitt's lymphoma) cell lines were purchased from CASCB (Chinese Academy of Sciences Cell Bank).

Techniques: Construct, In Vitro, Transduction, Expressing, Control, Over Expression, Release Assay, Cell Culture